Benzinga | Aug 13, 2020 04:04PM EDT

Acer Therapeutics Q2 EPS $(0.56) Up From $(1.09) YoY

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.56) per share. This is a 48.62 percent increase over losses of $(1.09) per share from the same period last year.